CMS Global Life Sciences & Healthcare Forum 2019

We have the pleasure to cordially invite you to our 

on Thursday, 21 November 2019, at 09:30 CET in Frankfurt.

The Forum will provide insights from external experts and CMS specialists on four core themes currently shaking up the Life Sciences and Healthcare sectors:

1. Revolution underway: The rise of gene and immune therapies

• Biotech industry: Current developments and key legal challenges
• Disruptive technologies in gene therapies: CRISPR & Co.

2. New approaches: How to collaborate today in the Life Sciences industry

• Investment strategies: New technologies, new need for investments?
• Blurring the lines and thinking outside the box: New forms of cooperation

3. Thinking the unthinkable: What the digital transformation means to enhanced Life Science and Healthcare

• What digitisation means for Life Sciences and Healthcare companies today
• Surgeon support software: How AI can help improve clinical outcomes

4. The future of MedTech: Overcoming the challenges of the MDR and moving from products to integrated services

• Current challenges of the MDR and how to overcome them
• From products to services: MedTech in transition?

Confirmed speakers include:

• Michael Kahnert, Counsel, BIO Deutschland e. V.
• Thomas de Charentenay, Head of Innovation and Strategic Implementation, Sanofi Pasteur
• Justus Wolff, Managing Director, Syte Digital Health Strategies
• Ulrich Juknat, General Counsel, Johnson & Johnson Medical GmbH
• Dr Christina Zimmer, Head of the MDR Unit, BVMed - German Association of Medical Technology Companies
• Steve Aherne, Head of Life Sciences and Pharmaceuticals Valuations, PwC
• Issy Corbett, Head of Healthcare Transactions, PwC
• CMS experts from different jurisdictions

A more detailed program will follow in due course. We invite you to register online via the register button below. This event is offered to you at no charge.